Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,714	1,887	602	608	185	384
Market Cap Growth	34.90%	213.59%	-1.10%	229.32%	-51.88%	39.68%
Enterprise Value	2,542	1,611	503	533	95	206
Last Close Price	15.43	12.37	5.05	7.00	3.14	7.87
PS Ratio	23.17	17.42	5.31	166.72	4.51	19.12
PB Ratio	19.86	8.68	12.67	-16.35	4.58	4.24
P/TBV Ratio	21.83	9.01	15.18	-	5.68	4.64
EV/Sales Ratio	23.27	14.87	4.44	146.02	2.33	10.24
Debt / Equity Ratio	0.15	0.12	0.68	-1.01	0.74	0.32
Asset Turnover	0.36	0.35	0.54	0.02	0.17	0.07
Quick Ratio	2.40	2.74	1.19	1.24	2.35	1.77
Current Ratio	2.51	2.89	1.26	1.38	2.53	1.90
Return on Equity (ROE)	-86.51%	-73.24%	-1118.17%	-10258.19%	-186.60%	-184.78%
Return on Assets (ROA)	-28.33%	-22.00%	-20.17%	-57.56%	-32.65%	-34.02%
Return on Capital (ROIC)	-51.67%	-42.80%	-106.22%	-287.75%	-83.45%	-85.55%
Return on Capital Employed (ROCE)	-87.40%	-45.80%	-76.80%	-217.40%	-88.90%	-97.00%
Earnings Yield	-4.49%	-5.14%	-9.56%	-26.60%	-66.17%	-39.05%
FCF Yield	-7.29%	-8.05%	-3.42%	-21.23%	-48.48%	-30.56%
Buyback Yield / Dilution	-30.63%	-30.33%	-34.55%	-52.16%	-32.12%	-15.83%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q